These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21186112)

  • 21. Glucagon-like peptide-1-(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3',5'-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes.
    Benito E; Blazquez E; Bosch MA
    Endocrinology; 1998 May; 139(5):2363-8. PubMed ID: 9564846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines.
    Sams A; Hastrup S; Andersen M; Thim L
    Eur J Pharmacol; 2006 Feb; 532(1-2):18-23. PubMed ID: 16448646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of glucagon-like peptide-1 receptor and calcium-sensing receptor signaling by L-histidine.
    Leech CA; Habener JF
    Endocrinology; 2003 Nov; 144(11):4851-8. PubMed ID: 12959987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.
    Angelone T; Quintieri AM; Brar BK; Limchaiyawat PT; Tota B; Mahata SK; Cerra MC
    Endocrinology; 2008 Oct; 149(10):4780-93. PubMed ID: 18535098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
    Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
    Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts.
    Pasqua T; Corti A; Gentile S; Pochini L; Bianco M; Metz-Boutigue MH; Cerra MC; Tota B; Angelone T
    Endocrinology; 2013 Sep; 154(9):3353-65. PubMed ID: 23751870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells.
    Ding L; Zhang J
    Acta Pharmacol Sin; 2012 Jan; 33(1):75-81. PubMed ID: 22120969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akt/eNOS signaling and PLN S-sulfhydration are involved in H₂S-dependent cardiac effects in frog and rat.
    Mazza R; Pasqua T; Cerra MC; Angelone T; Gattuso A
    Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R443-51. PubMed ID: 23785074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
    Salling HK; Döhler KD; Engstrøm T; Treiman M
    Regul Pept; 2012 Oct; 178(1-3):51-5. PubMed ID: 22749991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish.
    Imbrogno S; Garofalo F; Cerra MC; Mahata SK; Tota B
    J Exp Biol; 2010 Nov; 213(Pt 21):3636-43. PubMed ID: 20952611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
    Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
    Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway.
    Laviola L; Leonardini A; Melchiorre M; Orlando MR; Peschechera A; Bortone A; Paparella D; Natalicchio A; Perrini S; Giorgino F
    Endocrinology; 2012 Dec; 153(12):5770-81. PubMed ID: 23077074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
    Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
    J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
    Yusta B; Holland D; Waschek JA; Drucker DJ
    Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia.
    Huisamen B; Genade S; Lochner A
    Cardiovasc J Afr; 2008; 19(2):77-83. PubMed ID: 18516352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.